ACONAclarion Inc. Common Stock

NAS · US · Technology · Health Information Services · aclarion.com

2.710USD-2.17%Mkt Cap: 7.81M $P/E: —3d ago

Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The c…

Industry Peers

Health Information Services

Screen all

VEEV

Veeva Systems Inc Class A

$40.27BUSDP/E 44.0

TEM

Tempus AI Inc. Class A Common Stock

$13.12BUSD

BTSG

BrightSpring Health Services Inc. Common Stock

Hinge Health Inc. Class A Common Stock

$7.14BUSDP/E 10.8

WAY

Waystar Holding Corp. Common Stock

$4.80BUSDP/E 35.7

DOCS

Doximity Inc. Class A Common Stock

$4.51BUSDP/E 30.2

HTFL

Heartflow Inc. Common Stock

$4.33BUSD

PRVA

Privia Health Group, Inc.

Omada Health Inc. Common Stock

GoodRx Holdings, Inc.

Talkspace Inc. Common Stock

SOPHiA GENETICS SA Ordinary Shares

$736.36MUSD

Key Statistics

Company

Market Cap7.81M $

Enterprise Value-8.54M $

Revenue (TTM)83.77K $

Gross Profit6.83K $

Net Income (TTM)-7.23M $

Revenue/Share0.0570 USD

Last Price2.710 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees10

CountryUS

SectorTechnology

IndustryHealth Information Services

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.49

PEG—

EV/EBITDA0.90

EV/Revenue-101.97

P/S92.56

P/B0.39

EPS (TTM)-6.71

EPS (Forward)-5.47

52W Range

1.9508% of range12.03

52W High12.03 USD

52W Low1.950 USD

Profitability

Gross Margin9.02%

Oper. Margin-11503.18%

EBITDA Margin0.00%

Profit Margin-9551.87%

ROE-56.36%

ROA-52.91%

Growth

Revenue Growth30.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-7.16M $

CapEx (TTM)203.90K $

FCF Margin-6354.42%

FCF Yield-68.15%

Net Debt-16.30M $

Net Debt/EBITDA1.72

Balance Sheet

Debt/Equity—

Current Ratio16.20

Quick Ratio15.74

Book Value/Sh6.905 USD

Cash/Share5.653 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:27

Split DateMar 28, 2025

Analyst Consensus

Rating—

Target (Mean)7.500 USD

Upside (mean)+176.8%

Target Range7.500 USD – 7.500 USD

# Analysts1

Ownership

Shares Out.2.88M

Float2.62M

Insiders23.98%

Institutions4.00%

Short Interest

Short Ratio0.8d

Short % Float1.31%

Short % Out.1.31%

Shares Short32.25K

Short (prev mo.)54.62K

Technical

SMA 502.668 (+1.6%)

SMA 2003.802 (-28.7%)

Beta1.22

S&P 52W Chg18.16%

Avg Vol (30d)51.92K

Avg Vol (10d)77.91K

Technical Indicators

RSI (14)57.5

MACD-0.0236

MACD Signal-0.1046

MACD Hist.+0.0810

BB Upper2.798 USD

BB Middle2.382 USD

BB Lower1.966 USD

BB Width34.91%

ATR (14)0.1879 USD

Vol Ratio (20d)0.72x